av/newron-pharma-n--big.svg

COM:NEWRON

Newron Pharmaceuticals

  • Stock

CHF

Last Close

7.20

25/11 08:59

Market Cap

136.34M

Beta: -

Volume Today

6.96K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
3.54M
-
1.56M
56.00%
2.38M
52.86%
6.73M
182.61%
13.43M
99.64%
4.03M
70.03%
7.04M
74.86%
5.26M
25.29%
5.76M
9.59%
6.09M
5.76%
9.06M
48.62%
cost of revenue
269K
-
477K
77.32%
1.26M
164.57%
2.63M
108.72%
1.37M
-
1.43M
3.86%
295K
79.30%
gross profit
3.27M
-
1.08M
66.97%
1.12M
3.52%
4.09M
266.01%
13.43M
228.15%
2.65M
80.24%
5.61M
111.57%
4.96M
11.58%
5.76M
16.10%
6.09M
5.76%
9.06M
48.62%
selling and marketing expenses
15K
-
53K
253.33%
53K
0%
513K
867.92%
708K
38.01%
406K
42.66%
634K
56.16%
331K
47.79%
38K
88.52%
81K
113.16%
80K
1.23%
general and administrative expenses
3.79M
-
6.57M
73.31%
8.13M
23.68%
8.82M
8.59%
8.08M
8.48%
8.44M
4.52%
9.78M
15.82%
8.06M
17.55%
3.49M
56.66%
3.54M
1.23%
3.98M
12.61%
selling general and administrative expenses
3.81M
-
6.95M
82.55%
8.58M
23.47%
10.01M
16.72%
9.50M
5.13%
9.17M
3.48%
10.50M
14.50%
8.47M
19.30%
3.53M
58.32%
3.62M
2.44%
4.06M
12.30%
research and development expenses
4.54M
-
14.47M
218.87%
16.57M
14.55%
19.24M
16.09%
13.38M
30.43%
15.82M
18.20%
22.46M
41.97%
16.33M
27.29%
10.72M
34.32%
12.01M
11.93%
13.15M
9.55%
other expenses
2.97M
-
3.86M
-
3.77M
2.30%
cost and expenses
11.31M
-
12.39M
9.47%
27.49M
121.89%
22.04M
19.83%
18.85M
14.47%
19.12M
1.44%
26.82M
40.27%
22.70M
15.37%
18.12M
20.17%
19.40M
7.05%
20.69M
6.65%
operating expenses
11.31M
-
12.39M
9.47%
27.49M
121.89%
22.04M
19.83%
18.85M
14.47%
19.12M
1.44%
26.82M
40.27%
22.70M
15.37%
18.12M
20.17%
19.40M
7.05%
20.69M
6.65%
interest expense
-63K
-
132K
-
85K
35.61%
56K
34.12%
572K
921.43%
2.24M
291.43%
2.92M
30.33%
3.95M
35.26%
4.17M
5.60%
ebitda
-7.74M
-
-9.06M
17.06%
-17.60M
94.37%
-15.29M
13.13%
-4.05M
73.53%
-14.79M
265.27%
-20.85M
40.99%
-17.99M
13.69%
-11.76M
34.66%
-13.32M
13.32%
-11.83M
11.20%
operating income
-7.78M
-
-9.09M
16.90%
-17.68M
94.44%
-15.32M
13.30%
-4.10M
73.27%
-14.98M
265.67%
-20.90M
39.53%
-18.07M
13.56%
-12.36M
31.60%
-13.30M
7.65%
-11.63M
12.58%
depreciation and amortization
39K
-
33K
15.38%
71K
115.15%
33K
53.52%
48K
45.45%
192K
300%
52K
72.92%
72K
38.46%
600K
733.33%
-21K
103.50%
201K
1,057.14%
total other income expenses net
63K
-
-1.63M
2,692.06%
-7.31M
347.52%
121K
101.66%
-1.21M
1,095.87%
-41K
96.60%
737K
1,897.56%
-1.55M
310.58%
-2.53M
62.82%
-4.17M
65.02%
-4.57M
9.62%
income before tax
-7.71M
-
-10.72M
39.03%
-24.98M
132.99%
-15.20M
39.14%
-5.30M
65.13%
-15.02M
183.32%
-20.16M
34.24%
-19.62M
2.70%
-14.88M
24.13%
-17.47M
17.39%
-16.20M
7.28%
income tax expense
-615K
-
628K
202.11%
2.17M
245.06%
33K
98.48%
19K
42.42%
16K
15.79%
45K
181.25%
1.38M
2,966.67%
17K
98.77%
21K
23.53%
24K
14.29%
net income
-7.10M
-
-10.10M
42.22%
-22.82M
126.01%
-15.24M
33.22%
-5.28M
65.33%
-15.04M
184.65%
-20.21M
34.40%
-21.00M
3.91%
-14.90M
29.04%
-17.49M
17.39%
-16.22M
7.25%
weighted average shs out
11.51M
-
12.69M
10.24%
13.72M
8.17%
14.69M
7.04%
16.30M
10.97%
17.84M
9.47%
17.84M
0.01%
17.84M
0%
17.84M
0%
17.84M
0%
17.84M
0%
weighted average shs out dil
11.51M
-
12.69M
10.24%
13.72M
8.17%
14.69M
7.04%
16.30M
10.97%
17.84M
9.47%
17.84M
0.01%
17.84M
0%
17.84M
0%
17.84M
0%
17.84M
0%
eps
-0.62
-
-0.80
29.03%
-1.66
107.50%
-1.04
37.35%
-0.32
69.23%
-0.84
162.50%
-1.13
34.52%
-1.18
4.42%
-0.84
28.81%
-0.98
16.67%
-0.91
7.14%
epsdiluted
-0.62
-
-0.80
29.03%
-1.66
107.50%
-1.04
37.35%
-0.32
69.23%
-0.84
162.50%
-1.13
34.52%
-1.18
4.42%
-0.84
28.81%
-0.98
16.67%
-0.91
7.14%

All numbers in CHF (except ratios and percentages)